Home Advanced Medicine Comparing Results for 80 mg versus 160 mg Osimertinib in Advanced EGFR+ NSCLC
Comparing Results for

Comparing Results for 80 mg versus 160 mg Osimertinib in Advanced EGFR+ NSCLC

14 second read
0
69



Myung-Ju Ahn, MD, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, discusses the findings from the AURA …

source

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Check Also

Dr. McGregor on Choosing Combo Regimens in Advanced RCC – OncLive

[embedded content] Bradley McGregor, MD, clinical director, Lank Center for Genitouri…